Search Results for:

Biosimilar Drug Trends for 2020

The Florida Alliance for Healthcare Value hosted a webinar on September 22, 2020, in partnership with its affiliate member Amgen. Chad Pettit, Amgen's Executive Director of Marketing and Global Biosimilars Commercial Lead, shared highlights of the company's 2020 Biosimilar Trends Report.

Read More

Summer Education Series Explored Some of the Biggest Healthcare Challenges Facing Employers

Despite the pandemic, the Florida Alliance continues to feature highly accomplished speakers who are leaders in their field. Each session in the Summer Education Series featured nationally renowned experts who shared best practices and case studies on session topics and commented on related Florida Alliance initiatives. A key element of the presentations and discussion was what role providers, employers/purchasers, health plans, manufacturers, PBMs and patients need to play to move efforts toward affordable, quality heath care forward.

Read More

Migraine Headache and the
COVID-19 Pandemic

Approximately 13 percent of Americans experience migraine headaches, a recurring type of headache that causes severe, throbbing or pulsing pain and can be accompanied by nausea and sensitivity to light and sound. In the working population, migraine headache is the fifth most disabling medical condition in the United States.

Read More

Economic Costs of the Opioid Crisis for Employers

A considerable portion of the nearly $631 billion dollars in economic costs (estimated total US costs from 2015-2018) of the opioid crisis is borne by employers, including increased spending on health care and lost productivity. To better manage their financial risks and improve the health of their employees, employers should consider strategies that encompass both preventative and supportive measures to help those experiencing opioid use disorder (OUD) better manage their conditions and move toward recovery.

Read More

Milliman Research Report

Study results reveal individuals with both behavioral and physical health conditions see little spending on behavioral health treatment.

Read More

The State of the Opioid Crisis in Florida and a Comprehensive Alternative Treatment Approach for Substance Use Disorder

This two-hour session opened with Sheriff Dennis Lemma, a state and national leader fighting the opioid crisis, followed by an expert panel discussion on comprehensive and effective addiction recovery.

Read More

Trends and Policy Changes in the Drug Value Chain: Five Employer Actions and Recommendations

This two-hour session featured industry veteran Alex Jung, MBA, Partner & Managing Director of EY-Parthenon, who covered trends and policy changes in the drug value chain.

Read More